The Magicx journal · topic
6 articles to explore, from first steps to what comes next.
Utah became the first US state to grant AI systems authority over prescription renewals. Here is what this regulatory shift means for healthcare businesses, providers, and patients.
The AI-powered elder care market is projected to reach $208 billion by 2032 with a 25.26% CAGR. This complete guide covers voice assistants, health wearables, companion AI, fall detection, medication management, and simplified interfaces — with product comparisons, setup guides, and cost breakdowns.
Digital twins and AI are reducing clinical trial timelines from 10-15 years to 5-7 years while improving success rates. This guide covers the technology, FDA frameworks, key platforms, and implementation strategies for healthcare and biotech organizations.
Over 40 million people now use AI therapy apps monthly. We review the clinical evidence, compare top platforms like Wysa, Headspace Ebb, and Replika, and explain when AI therapy helps vs. when you need a human therapist.
Amazon launched a healthcare AI assistant in March 2026, joining Anthropic's HIPAA-ready infrastructure and Google's medical AI. Here's the emerging battle for the patient-provider AI interface and what it means for healthcare.
AI-driven drug discovery is slashing traditional pharma timelines by 80%. With multiple AI-discovered drugs now in Phase II trials, the biotech investment landscape is being rewritten.